Initial assessment of the ability of ivermectin to kill Ixodes scapularis and Dermacentor variabilis ticks feeding on humans

Evaluation of Human Attachment by Larval Amblyomma maculatum (Acari: Ixodidae)

The tick, Amblyomma maculatum Koch (Gulf Coast tick), has recently been shown to be an important disease vector of both medical and veterinary concern. Although much is known about the behavior and ecology of adults, little is known of the immatures. Larval feeding on humans has never been demonstrated (and thus, there are no collection records from humans). In this experiment, 10 larval A. maculatum, Amblyomma americanum (L.) (a positive control), and Dermacentor variabilis (Say) (a negative control), were applied to both forearms of 10 human volunteers (five male, five female). Ticks were placed in plastic caps and secured to skin with medical-grade adhesive tape, and volunteers remained sedentary during the experiment. After 15 min, caps were removed, and attachment was determined using fine-tipped forceps. Any A. maculatum that were attached were then removed and subsequently examined microscopically to verify identification. In total, 34 ticks attached to the subjects, including 11 A. maculatum (5.5%), 23 A. americanum (11.5%), and no D. variabilis. Amblyomma maculatum attached to six volunteers, and no apparent association between gender and attachment rate was noted. No skin lesions developed in the human volunteers bit by A. maculatum. This is the first report of larval A. maculatum attaching to humans, and is significant in that Rickettsia parkeri, a human pathogen vectored by this species, has recently been reported to be transmitted transovarially. If A. maculatum are infected as larvae, they could potentially transmit R. parkeri to people.

The use of ivermectin to kill ixodes scapularis ticks feeding on humans

OBJECTIVE

The purpose of this study was to determine whether 400 µg/kg oral ivermectin is able to kill Ixodes scapularis nymphs and adult female ticks feeding on humans.

METHODS

Ten study subjects each wore 2 ostomy bags, the one containing 24 I scapularis nymphs, and the other containing 24 I scapularis adult females. Twenty-four hours after the ostomy bags were attached, study subjects received either 400 µg/kg ivermectin or placebo. Thirty hours after the ivermectin or placebo was consumed, the ticks were removed, and mortality determined in a double-blinded manner.

RESULTS

Eleven percent of the I scapularis nymphs attached in the ivermectin group compared with 17% in the placebo. Mortality for the I scapularis nymphs that attached at the time of removal was 55% in the ivermectin group and 47% in the placebo group. Mortality for the I scapularis nymphs 5 days after removal was 92% in the ivermectin group and 88% for the placebo. Three percent of the I scapularis adults attached in the ivermectin group compared with 9% in the placebo group. Mortality for I scapularis adults was 0% on day 3 and 33% on day 8 for both the ivermectin and placebo groups. There were statistically insignificant differences in the mortality rates between I scapularis nymphs and adults exposed to ivermectin or placebo.

CONCLUSIONS

There were a high number of ticks that died in both groups but the data do not support our hypothesis that ivermectin can kill I scapularis. The study was not designed to determine whether it could prevent the transmission of tick-borne illness.